Latest News
Tuesday November 4, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that its subsidiary, PLIVA - Lachema a.s., has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Pfizer Inc.'s Camptosar(R) (irinotecan hydrochloride) Inj...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Tuesday October 28, 2008 — Barr Pharmaceuticals, Inc.
JERUSALEM, Israel and MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that Barr and its syndicate of lending banks, arranged by Bank of America, have agreed to amend Barr's unsecured credit facilities to permit...
Monday October 27, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for LoSEASONIQUE(R) (levonorgestrel/ethinyl estradiol tablets 0.10 ...
Saturday October 25, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Watson Laboratories, Inc. in connection with its Oxytrol(R) (oxybutynin transdermal system). The Company b...
Wednesday October 22, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its Opana(R) ER (oxymorphone hydrochloride) extended-release ...
Saturday October 18, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 17 Barr Pharmaceuticals, Inc. today announced that the Company has revised the time of its conference call to discuss earnings results for the third quarter of calendar 2008, ended September 30, 2008. The Company revised the time of its Conference Call to 9:00 AM Eastern time...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has upheld the 2005 decision of the U.S. District Court for the Eastern District of New York, which rejected a challenge to the lawfulness of a 1997...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...
Thursday October 16, 2008 — Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that a special meeting of shareholders to vote on the proposed acquisition of Barr Pharmaceuticals, Inc. by Teva Pharmaceutical Industries Ltd. has been set for November 21, 2008. The meeting will be he...